Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects

NCT02689661 is registered in ClinicalTrials.gov with Brian Callaghan as lead sponsor.

NCT NCT02689661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02689661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
Lead sponsor
Brian Callaghan
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
December 31, 2019
Enrollment
177 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, neuropathy, obesity